Zolbetuximab
from OncoPharm Hosted by John Bossaer
The first Cldn 18.2 targeting monoclonal antibody has been improved. Let's talk about it!
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OncoPharm?
This episode is 19 minutes long.
When was this OncoPharm episode published?
This episode was published on October 31, 2024.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.